Follow on Telegram

science/health

Technology News

Apple Vision Pro Gains FDA Clearance for Surgical Use in Hip Arthroscopy

Apple's Vision Pro headset is finding a new application in operating rooms. Stryker announced that its SportSuite Vision software, designed for the Apple Vision Pro, has received De Novo authorization from the U.S. Food and Drug Administration (FDA). The authorization, granted in July, clears the way for

Study Reveals One in Five Teenagers Use AI Tools for Mental Health Guidance

A new study has highlighted a notable shift in how teenagers seek mental health support, with roughly one in five now turning to artificial intelligence tools for guidance. The research, cited by sources including the Independent Medical Alliance, found that platforms like ChatGPT and other AI assistants have become increasingly

Examining the Evidence: Human-AI Collaboration in Healthcare Settings

Healthcare researchers are increasingly focused on understanding not just what AI systems can do in medical contexts, but how they can collaborate meaningfully with human clinicians. A newly assembled Nature collection, "Human-AI Collaboration in Healthcare: Evidence in Practice," brings together research examining real-world implementation of these partnerships. The

Scientists Discover Unique Dual Antibody System That May Explain How Bats Tolerate Dangerous Viruses

A Unique Immune Architecture in Bats Bats are notorious reservoirs for viruses that prove deadly in other species—from rabies and Ebola to SARS-CoV-2. Yet infected bats rarely show symptoms of disease. A new study reveals a possible explanation: a dual antibody gene system that appears unique among mammals. Two

AI Approach Enables Gene-Editing Tool Optimization Under Data Constraints

Gene-editing technologies like CRISPR have transformed molecular biology, but optimizing these tools often requires extensive experimental data that can be costly and time-consuming to generate. A team at the University of Pennsylvania has shown that AI can bridge this gap, enabling meaningful improvements to gene-editing systems even under data-sparse conditions.

AI Drug Discovery Accelerates, but Testing Phase Remains a Costly Bottleneck

The integration of artificial intelligence into pharmaceutical research is dramatically accelerating the early stages of drug discovery. AI models can now analyze vast datasets to identify promising drug candidates and predict their efficacy at an unprecedented pace. However, this acceleration at the front end of development is creating a paradox:

FDA Launches Pilot Program for Generative AI Medical Devices

The U.S. Food and Drug Administration (FDA) has launched a pilot program that aims to facilitate earlier patient access to generative AI medical devices before they complete the full regulatory authorization process. The initiative represents a structured approach to balancing innovation in healthcare AI with appropriate oversight. Under the